NCT04601857 2025-12-31Futibatinib and Pembrolizumab Combination in the Treatment of Advanced or Metastatic Urothelial CarcinomaTaiho Oncology, Inc.Phase 2 Terminated43 enrolled 15 charts
NCT04024436 2025-11-13A Study of TAS-120 in Patients With Metastatic Breast CancerTaiho Oncology, Inc.Phase 2 Terminated64 enrolled 21 charts
NCT04189445 2025-10-08Futibatinib in Patients With Specific FGFR AberrationsTaiho Oncology, Inc.Phase 2 Terminated115 enrolled 19 charts